Global In-Vitro Toxicology Testing Market Report By Technology (Cell Culture Technology, High Throughput Technology, Molecular Imaging, OMICS Technology), By Method (Cellular Assay, Biochemical Assay, In Silico, Ex-vivo), By Application (Systemic Toxicology, Dermal Toxicity, Endocrine Disruption, Ocular Toxicity, Others), By End-Use (Pharmaceutical Industry, Cosmetics & Household Products, Diagnostics, Chemicals Industry, Food Industry) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2021-2028

Name: Global In-Vitro Toxicology Testing Market Report
Brand: Value Market Research
SKU: Healthcare
Price: 3950.00 USD
Availability: OnlineOnly
Rating: 4.2 (80 reviews)

ID:VMR11213719

April 2021

Report Formats: Electronic (PDF), MS EXCEL

Description
Table Of Content

The global demand for In-Vitro Toxicology Testing Market is presumed to reach the valuation of nearly USD XX MN by 2028 from USD XX MN in 2021 with a CAGR of XX% under the study period of 2022 - 2028.

In vitro toxicology testing is a scientific method used to examine the toxic properties of chemical compounds and mixtures on cells or tissues maintained or grown in controlled laboratory conditions. This analysis method is used in the early stages of developing new therapeutic drugs, agricultural chemicals, and food additives. Several in vitro screening assays are available to measure the specific biological activities of chemicals in particular cells or organs and elucidate the action mechanisms. The assay choice depends on the cell type and an in-depth understanding of the relation between a chemical's toxicity and the biological pathways crucial for efficient testing.

Market Dynamics

The growing popularity of the cost-effective In vitro toxicity testing method because of faster test results than toxicology studies in living animals is the main driver for this growth. This laboratory testing method can help manufacturers get their products to the market faster and reduce overall costs. The continued development of assays to test a wide range of chemicals used in several end-user industries like solvents, dyes, preservatives, plasticizers, therapeutic agents, drinking water-disinfection byproducts, etc. will benefit market growth. The increased use of this testing method in the robust cosmetics industry will be a market booster. A major roadblock for this market is the limited biological space covered by a specific assay and lack of knowledge regarding the complicated mechanism involved in a chemical's toxicity.

The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level.

Additionally, these tools also give inclusive assessment of each application/product segment in the global market of in-vitro toxicology testing.

Market Segmentation

The report segments the anthracite market and analyses it with respect to the geography, intending to keep the marketer informed and help them identify the target demographics for the product or service.

By Technology

Cell Culture Technology
High Throughput Technology
Molecular Imaging
OMICS Technology

By Method

Cellular Assay
Biochemical Assay
In Silico
Ex-vivo

By Application

Systemic Toxicology
Dermal Toxicity
Endocrine Disruption
Ocular Toxicity
Others

By End-Use

Pharmaceutical Industry
Cosmetics & Household Products
Diagnostics
Chemicals Industry
Food Industry

Regional Analysis

This section covers regional segmentation which accentuates on current and future demand for In-Vitro Toxicology Testing market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.

Global In-Vitro Toxicology Testing Market Share by Region (Representative Graph)

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the In-Vitro Toxicology Testing market include Agilent Technologies, Abbott, Bio-Rad Laboratories, Inc., Merck KGaA, Charles River, Thermo Fisher Scientific Inc., Catalent, Inc., Eurofins Scientific, GE Healthcare, Quest Diagnostics Incorporated, Laboratory Corporation of America Holdings, Evotec, Creative Bioarray, Gentronix, HD Biosciences Co., Ltd. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY
       2.1. Highlights of In-Vitro Toxicology Testing Market
       2.2. Global In-Vitro Toxicology Testing Market Snapshot

3 . IN-VITRO TOXICOLOGY TESTING – INDUSTRY ANALYSIS
       3.1. Introduction
       3.2. Market Drivers of In-Vitro Toxicology Testing Market
       3.3. Market Restraints of In-Vitro Toxicology Testing Market
       3.4. Opportunities of In-Vitro Toxicology Testing Market
       3.5. Trends of In-Vitro Toxicology Testing Market
       3.6. Porter’s Five Force Analysis of In-Vitro Toxicology Testing Market
       3.7. In-Vitro Toxicology Testing Market Attractiveness Analysis
           3.7.1 Market Attractive Analysis by Technology
           3.7.2 Market Attractive Analysis by Method
           3.7.3 Market Attractive Analysis by Application
         3.7.4 Market Attractive Analysis by End-Use
           3.7.5 Market Attractive Analysis by Region

4 . VALUE CHAIN ANALYSIS
       4.1. In-Vitro Toxicology Testing Value Chain Analysis
       4.2. In-Vitro Toxicology Testing Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. In-Vitro Toxicology Testing Raw Material Manufactures List
           4.2.3. Price Trend of In-Vitro Toxicology Testing Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK
       5.1. Impact Analysis of Covid-19 Outbreak on In-Vitro Toxicology Testing Market
           5.1.1. Direct Impact on Production
           5.1.2. Supply Chain and Market Disruption
           5.1.3. Financial Impact on Firms and Financial Markets
       5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
       5.3. In-Vitro Toxicology Testing Market: Pre V/S Post COVID-19
       5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the In-Vitro Toxicology Testing Market
       5.5. COVID-19: Micro and Macro Factor Analysis on In-Vitro Toxicology Testing Market

6 . GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET ANALYSIS BY TECHNOLOGY
       6.1 Overview by Technology
       6.2 Historical Data 2016-2019
       6.3 Global In-Vitro Toxicology Testing Market Analysis by Technology
       6.4 Market Analysis of Cell Culture Technology by Regions
       6.6 Market Analysis of High Throughput Technology by Regions
       6.5 Market Analysis of Molecular Imaging by Regions
       6.7 Market Analysis of OMICS Technology by Regions

7 . GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET ANALYSIS BY METHOD
       7.1 Overview by Method
       7.2 Historical Data 2016-2019
       7.3 Global In-Vitro Toxicology Testing Market Analysis by Method
       7.4 Market Analysis of Cellular Assay by Regions
       7.5 Market Analysis of Biochemical Assay by Regions
       7.6 Market Analysis of In Silico by Regions
       7.7 Market Analysis of Ex-vivo by Regions

8 . GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET ANALYSIS BY APPLICATION
       8.1 Overview by Application
       8.2 Historical Data 2016-2019
       8.3 Global In-Vitro Toxicology Testing Market Analysis by Application
       8.4 Market Analysis of Systemic Toxicology by Regions
       8.5 Market Analysis of Dermal Toxicity by Regions
       8.6 Market Analysis of Endocrine Disruption by Regions
       8.7 Market Analysis of Ocular Toxicity by Regions
       8.8 Market Analysis of Others by Regions

9 . GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET ANALYSIS BY END-USE
       9.1 Overview by End-Use
       9.2 Historical Data 2016-2019
       9.3 Global In-Vitro Toxicology Testing Market Analysis by End-Use
       9.4 Market Analysis of Pharmaceutical Industry by Regions
       9.5 Market Analysis of Cosmetics & Household Products by Regions
       9.6 Market Analysis of Diagnostics by Regions
       9.7 Market Analysis of Chemicals Industry by Regions
       9.8 Market Analysis of Food Industry by Regions

10 . GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET ANALYSIS BY GEOGRAPHY
       10.1. Regional Outlook
       10.2. Introduction
       10.3. North America
           10.3.1. Overview and Historic Data
           10.3.2. North America In-Vitro Toxicology Testing Market Estimate By Market Segment
           10.3.3. North America In-Vitro Toxicology Testing Market Estimate By Country
           10.3.4. United State
           10.3.5. Canada
           10.3.6. Mexico
       10.4. Europe
           10.4.1. Overview and Historic Data
           10.4.2. Europe In-Vitro Toxicology Testing Market Estimate by Market Segment
           10.4.3. Europe In-Vitro Toxicology Testing Market Estimate by Country
           10.4.4. United Kingdom
           10.4.5. France
           10.4.6. Germany
           10.4.7. Italy
           10.4.8. Russia
           10.4.9. Rest Of Europe
       10.5. Asia Pacific
           10.5.1. Overview and Historic Data
           10.5.2. Asia Pacific In-Vitro Toxicology Testing Market Estimate by Market Segment
           10.5.3. Asia Pacific In-Vitro Toxicology Testing Market Estimate by Country
           10.5.4. China
           10.5.5. India
           10.5.6. Japan
           10.5.7. South Korea
           10.5.8. Australia
           10.5.9. Rest Of Asia Pacific
       10.6. Latin America
           10.6.1. Overview and Historic Data
           10.6.2. Latin America In-Vitro Toxicology Testing Market Estimate by Market Segment
           10.6.3. Latin America In-Vitro Toxicology Testing Market Estimate by Country
           10.6.4. Brazil
           10.6.5. Argentina
           10.6.6. Peru
           10.6.7. Chile
           10.6.8. Rest of Latin America
       10.7. Middle East & Africa
           10.7.1. Overview and Historic Data
           10.7.2. Middle East & Africa In-Vitro Toxicology Testing Market Estimate by Market Segment
           10.7.3. Middle East & Africa In-Vitro Toxicology Testing Market Estimate by Country
           10.7.4. Saudi Arabia
           10.7.5. UAE
           10.7.6. Israel
           10.7.7. South Africa
           10.7.8. Rest Of Middle East And Africa

11 . COMPETITIVE LANDSCAPE OF THE IN-VITRO TOXICOLOGY TESTING COMPANIES
       11.1. In-Vitro Toxicology Testing Market Competition
       11.2. Partnership/Collaboration/Agreement
       11.3. Merger And Acquisitions
       11.4. New Product Launch
       11.5. Other Developments

12 . COMPANY PROFILES OF IN-VITRO TOXICOLOGY TESTING INDUSTRY
       12.1. Company Share Analysis
       12.2. Market Concentration Rate
       12.3. Agilent Technologies
           12.3.1. Company Overview
           12.3.2. Financials
           12.3.3. Products
           12.3.4. Recent Developments
       12.4. Abbott
           12.4.1. Company Overview
           12.4.2. Financials
           12.4.3. Products
           12.4.4. Recent Developments
       12.5. Bio-Rad Laboratories, Inc.
           12.5.1. Company Overview
           12.5.2. Financials
           12.5.3. Products
           12.5.4. Recent Developments
       12.6. Merck KGaA
           12.6.1. Company Overview
           12.6.2. Financials
           12.6.3. Products
           12.6.4. Recent Developments
       12.7. Charles River
           12.7.1. Company Overview
           12.7.2. Financials
           12.7.3. Products
         12.7.4. Recent Developments
       12.8. Thermo Fisher Scientific Inc.
           12.8.1. Company Overview
           12.8.2. Financials
           12.8.3. Products
           12.8.4. Recent Developments
       12.9. Catalent, Inc.
           12.9.1. Company Overview
           12.9.2. Financials
           12.9.3. Products
           12.9.4. Recent Developments
       12.10. Eurofins Scientific
           12.10.1. Company Overview
           12.10.2. Financials
           12.10.3. Products
           12.10.4. Recent Developments
       12.11. GE Healthcare
           12.11.1. Company Overview
           12.11.2. Financials
           12.11.3. Products
           12.11.4. Recent Developments
       12.12. Quest Diagnostics Incorporated
           12.12.1. Company Overview
           12.12.2. Financials
           12.12.3. Products
           12.12.4. Recent Developments
       12.13. Laboratory Corporation of America Holdings
           12.13.1. Company Overview
           12.13.2. Financials
           12.13.3. Products
           12.13.4. Recent Developments
       12.14. Evotec
           12.14.1. Company Overview
           12.14.2. Financials
           12.14.3. Products
           12.14.4. Recent Developments
       12.15. Creative Bioarray
           12.15.1. Company Overview
           12.15.2. Financials
           12.15.3. Products
           12.15.4. Recent Developments
       12.16. Gentronix
           12.16.1. Company Overview
           12.16.2. Financials
           12.16.3. Products
           12.16.4. Recent Developments
       12.17. HD Biosciences Co., Ltd.
           12.17.1. Company Overview
           12.17.2. Financials
           12.17.3. Products
           12.17.4. Recent Developments

*Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

LIST OF FIGURES

* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Choose your Buying Option

Single User License: $ 3950.00

Upto 10 Users License: $ 4950.00

Enterprise License: $ 8600.00

Data Pack: $ 2100.00

Buy Now

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

Buy sections of this report
Buy country level reports
Request for historical data
Request discounts available for Start-Ups & Universities

Request for Special Pricing

Objectives of Study

Define and measure the global market
Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
Analyze and identify major market trends along with the factors driving or inhibiting the market growth
Study the company profiles of the major market players with their market share
Analyze competitive developments

Why Choose Us

Client First Policy

Excellent Quality

After Sales Support

24/7 Email Support

Clients

Testimonials

" Doing business with Value Market Research was – quick, easy and accurate. We got what we expected. The team was very helpful and processes were altered for our convenience. The whole process from understanding our niche requirements to delivery to after sales was excellent. "

Vincenzo Baydar – Head Planning, Leading Food Chain, US

" Excellent work!! Working with you has been easy and direct. Your flexibility to alter the report scope and timely delivery assisted me in delivering my project proposal on time. "

Mia Tang, Director - Business Strategy, Steel Industry, Germany

" This is our second purchase and we have been obliged by the service. We appreciate the efforts put by Value Market Research in terms of understanding our needs, expanding the scope of the study, delivery and handling after sales queries. "